Pancreatic Cancer Research

ResearcherUniversity of IowaActive in the last 2 years

Jingru Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4157-4647; OpenAlex author ID A5100420005. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2019: 2 papers · 2020: 1 paper · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-026-69055-2↗
  2. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-025-65811-y↗
  3. Poor dental health and risk of pancreatic cancer: a nationwide registry-based cohort study in Sweden, 2009-2016. Co-author DOI 10.1038/s41416-022-02018-8↗
  4. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.33464↗
  5. Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039. Co-author DOI 10.1002/ijc.33617↗
  6. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. Co-author DOI 10.1136/gutjnl-2019-319990↗
  7. Gastric Mucosal Abnormality and Risk of Pancreatic Cancer: A Population-Based Gastric Biopsy Cohort Study in Sweden. Co-author DOI 10.1158/1055-9965.epi-21-0580↗
  8. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. Co-author DOI 10.1158/1055-9965.epi-19-1027↗
  9. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. Co-author DOI 10.1002/ijc.31866↗
  10. Survival Benefits of Chemotherapy for Patients with Advanced Pancreatic Cancer in A Clinical Real-World Cohort. First author DOI 10.3390/cancers11091326↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weimin Ye · 7 shared papers, 2019–2022 · strength 0.87
  2. Matthias J. Löhr · 6 shared papers, 2019–2021 · strength 0.62
  3. Núria Malats · 4 shared papers, 2019–2021 · strength 0.33
  4. Alfredo Carrato · 4 shared papers, 2019–2021 · strength 0.33
  5. Francisco X. Real · 4 shared papers, 2019–2021 · strength 0.33
  6. Maximilian Kordes · 2 shared papers, 2019–2021 · strength 0.24
  7. Paulina Gómez-Rubio · 3 shared papers, 2019–2021 · strength 0.22
  8. Linda Sharp · 3 shared papers, 2019–2021 · strength 0.22
  9. Esther Molina‐Montes · 3 shared papers, 2019–2021 · strength 0.22
  10. Luis Muñoz‐Bellvís · 3 shared papers, 2019–2021 · strength 0.22
  11. Rita Teresa Lawlor · 3 shared papers, 2019–2021 · strength 0.22
  12. J. Enrique Domínguez‐Muñoz · 3 shared papers, 2019–2021 · strength 0.22
  13. William Greenhalf · 3 shared papers, 2019–2021 · strength 0.22
  14. Christoph W. Michalski · 3 shared papers, 2019–2021 · strength 0.22
  15. Jorg H. Kleeff · 3 shared papers, 2019–2021 · strength 0.22
  16. Bo Kong · 3 shared papers, 2019–2021 · strength 0.22
  17. Tatjana Crnogorac‐Jurcevic · 3 shared papers, 2019–2021 · strength 0.22
  18. Thomas Mathias Gress · 3 shared papers, 2019–2021 · strength 0.22
  19. Aldo Scarpa · 3 shared papers, 2019–2021 · strength 0.22
  20. Eithne Costello · 3 shared papers, 2019–2021 · strength 0.22
  21. Margaret Chen · 1 shared paper, 2022 · strength 0.19
  22. Maria Gustafsson Liljefors · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.